AccScience Publishing / ITPS / Volume 1 / Issue 1 / DOI: 10.26689/itps.v1i1.417
Cite this article
19
Download
561
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
MINI-REVIEW

Korean Red Ginseng: Benefits Versus Precautions

Essam A. Makky1
Show Less
1 Department of Industrial Biotechnology, Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 Gambang, Kuantan, Pahang, Malaysia
INNOSC Theranostics and Pharmacological Sciences 2018, 1(1), 417 https://doi.org/10.26689/itps.v1i1.417
Submitted: 18 October 2018 | Accepted: 14 November 2018 | Published: 4 December 2018
© 2018 by the Authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Over the years, Korean red ginseng (RG), scientifically known as Panax ginseng, has been used to treat several diseases. 
It is a prominent and ancient medicinal herb in the Orient. Ginseng ginsenoside is the major component of RG which has been presumed to be responsible for the health benefits of RG. Many studies on P. ginseng have until now concentrated on the mechanism of action of the individual components of RG. However, despite the numerous research on the molecular basis of P. ginseng activities, it is still confusing how several active components can simultaneously interact with several targets to give the diverse effects in different diseases. This overview covered the positive and negative effects of using the Korean RG; it also outlined the major chemical components of the Korean RG.

Keywords
Red ginseng
Panax ginseng
ginsenoside
side effects
Araliaceae
adaptogens
References
[1]

Brekhman, I.I.; Dardymov, I.V. New substances of plant origin which increase nonspecific resistance. Annu. Rev. Pharmacol., 1969, 9, 419-430.

[2]

Nag, S.A.; Qin, J.J.; Wang, W.; Wang, M.H.; Wang, H.; Zhang, R. Ginsenosides as anticancer agents: In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol., 2012, 25, 1-18.

[3]

Seo, J.Y.; Lee, J.H.; Kim, N.W.; Her, E.; Chang, S.H.; Ko, N Y.; Yoo, Y.H.; Kim, J.W.; Seo, D.W.; Han, J.W.; Kim, Y.M.; Choi, W S. Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. Int. Immunopharmacol., 2005, 5(5), 929-936.

[4]

Zhu, J.; Mu, X.; Zeng, J.; Xu, C.; Liu, J.; Zhang, M.; Li, C.; Chen, J.; Li, T.; Wang, Y. Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging. PLoS One, 2014, 9(6), e101291.

[5]

Gotteeman, M.M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug trans-port. Annu. Rev. Biochem., 1993, 62, 385-427.

[6]

Park, J.D.; Kim, D.S.; Kwon, H.Y.; Son, S.K.; Lee, Y.H.; Baek, N.I.; Kim, S.I.; Rhee, D.K. Effect of ginseng saponin on modulation of multidrug resistance. Arch. Pharm. Res., 1996, 19, 213-218.

[7]

Kwon, H.Y.; Kim, E.H.; Kim, S.W.; Kim, S.N.; Park, J.D.; Rhee, D.K. Selective toxicity of ginsenoside Rg3 on multidrug resistance cells by membrane fluidity modulation. Arch. Pharm. Res., 2008, 31, 171-177.

[8]

Jin, J.; Shahi, S.; Kang, H.K.; Veen, H.W.; van, Fan T.P. Metabolite of ginsenosides as novel BCRP inhibitors. Biochem. Biophys. Res. Commun., 2006, 345, 1308-1314.

[9]

Kamangar, F.; Gao, Y.T.; Shu, X.O.; Kahkeshani, K.; Ji, B.T.; Yang, G.; Li, H.L.; Rothman, N.; Chow, W.H.; Zheng, W. Ginseng intake and gastric cancer risk in the Shanghai women’s health study cohort. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 629-630.

[10]

Rai, D.; Bhatia, G.; Sen, T.; Palit, G. Anti-stress effects of Ginkgo biloba and Panax ginseng: A comparative study. J. Pharmacol. Sci., 2003, 93(4), 458-464.

[11]

Lee, S.T.; Chu, K.; Sim, J.Y.; Heo, J.H.; Kim, M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis. Assoc. Disord., 2008, 22(3), 222-6.

[12]

Lee, J.S.; Choi, H.S.; Kang, S.W.; Chung, J.H.; Park, H.K.; Ban, J.Y.; Kwon, O.Y.; Hong, H.P.; Ko, Y.G. Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury. Am. J. Chin. Med., 2011, 39(1), 83-94.

[13]

Xie, J.T.; Zhou, Y.P.; Dey, L.; Attele, A.S.; Wu, J.A.; Gu, M.; Polonsky, K.S.; Yuan, C.S. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine, 2002, 9(3), 254-258.

[14]

Jang, D.J.; Lee, M.S.; Shin, B.C.; Lee, Y.C.; Ernst, E. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol., 2008, 66(4), 444-450.

[15]

Song, Z.; Johansen, H.K.; Faber, V.; Moser, C.; Kharazmi, A.; Rygaard, J.; Høiby, N. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob. Agents Chemother., 1997, 41(5), 961-964.

[16]

Reay, J.L.; Kennedy, D.O.; Scholey, A.B. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained ‘mentally demanding’ tasks. J. Psychopharmacol., 2006, 20(6), 771-781.

[17]

Wang, X.; Su, G.Y.; Zhao, C.; Qu, F.Z.; Wang, P.; Zhao, Y.Q. Anticancer activity and potential mechanisms of 1C, a ginseng saponin derivative, on prostate cancer cells. J. Ginseng Res., 2018, 42(2), 133-143.

[18]

Kang, S.; Min, H. Ginseng, the “immunity boost”: The effects of Panax ginseng on immune system. J. Ginseng Res., 2012, 36(4), 354-368.

[19]

Coon, J.T.; Ernst, E. Panax ginseng: A systematic review of adverse effects and drug interactions. Drug Saf., 2002, 25, 323-344.

[20]

Park, S.Y.; Park, J.H.; Kim, H.S.; Lee, C.Y.; Lee, H.J.; Kang, K S.; Kim, C.E. Systems-level mechanisms of action of Panax ginseng: A network pharmacological approach. J. Ginseng Res., 2018, 42(1), 98-106.

Conflict of interest
The author declares no conflict of interest in any kind.
Share
Back to top
INNOSC Theranostics and Pharmacological Sciences, Electronic ISSN: 2705-0823 Published by AccScience Publishing